PNC Financial Services Group’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$189K Hold
11,623
– – ﹤0.01% 2432
2026
Q2
$209K Hold
11,623
– – ﹤0.01% 2325
2026
Q1
$109K Sell
11,623
-912
-7% -$10K ﹤0.01% 2655
2025
Q4
$156K Hold
12,535
– – ﹤0.01% 2384
2025
Q3
$180K Buy
12,535
+67
+0.5% +$918 ﹤0.01% 2274
2025
Q2
$153K Sell
12,468
-3,400
-21% -$49.4K ﹤0.01% 2288
2025
Q1
$349K Buy
15,868
+320
+2% +$7.52K ﹤0.01% 1661
2024
Q4
$353K Buy
15,548
+3,746
+32% +$81.8K ﹤0.01% 1659
2024
Q3
$214K Sell
11,802
-5,516
-32% -$128K ﹤0.01% 2029
2024
Q2
$505K Buy
17,318
+4,365
+34% +$129K ﹤0.01% 1385
2024
Q1
$459K Sell
12,953
-154
-1% -$6.16K ﹤0.01% 1474
2023
Q4
$571K Sell
13,107
-127
-1% -$5K ﹤0.01% 1326
2023
Q3
$505K Sell
13,234
-7,193
-35% -$303K ﹤0.01% 1364
2023
Q2
$840K Sell
20,427
-1,739
-8% -$83.7K ﹤0.01% 1137
2023
Q1
$1.27M Buy
22,166
+265
+1% +$14.9K ﹤0.01% 962
2022
Q4
$1.23M Sell
21,901
-1,694
-7% -$86.2K ﹤0.01% 971
2022
Q3
$999K Buy
23,595
+1,100
+5% +$56.4K ﹤0.01% 1045
2022
Q2
$1.22M Sell
22,495
-352
-2% -$21.1K ﹤0.01% 1002
2022
Q1
$1.47M Sell
22,847
-3,912
-15% -$258K ﹤0.01% 981
2021
Q4
$1.79M Buy
26,759
+506
+2% +$34.2K ﹤0.01% 944
2021
Q3
$1.8M Buy
26,253
+594
+2% +$42K ﹤0.01% 881
2021
Q2
$1.75M Buy
25,659
+369
+1% +$26.1K ﹤0.01% 896
2021
Q1
$1.75M Buy
25,290
+1,092
+5% +$74K ﹤0.01% 862
2020
Q4
$1.57M Sell
24,198
-263
-1% -$14.2K ﹤0.01% 867
2020
Q3
$1.16M Sell
24,461
-4,280
-15% -$204K ﹤0.01% 905
2020
Q2
$1.35M Buy
28,741
+2,383
+9% +$117K ﹤0.01% 844
2020
Q1
$1.18M Buy
26,358
+1,500
+6% +$78.7K ﹤0.01% 823
2019
Q4
$1.45M Sell
24,858
-21,754
-47% -$1.29M ﹤0.01% 842
2019
Q3
$2.8M Sell
46,612
-10,506
-18% -$626K ﹤0.01% 785
2019
Q2
$3.19M Buy
57,118
+4,213
+8% +$217K ﹤0.01% 790
2019
Q1
$2.95M Sell
52,905
-1,006
-2% -$51.2K ﹤0.01% 834
2018
Q4
$2.43M Sell
53,911
-1,255
-2% -$68.9K ﹤0.01% 870
2018
Q3
$3.63M Buy
55,166
+1,724
+3% +$107K ﹤0.01% 805
2018
Q2
$3.44M Sell
53,442
-765
-1% -$47.4K ﹤0.01% 807
2018
Q1
$3M Sell
54,207
-2,991
-5% -$157K ﹤0.01% 830
2017
Q4
$2.74M Buy
57,198
+306
+0.5% +$15K ﹤0.01% 875
2017
Q3
$2.87M Buy
56,892
+37,094
+187% +$1.91M ﹤0.01% 842
2017
Q2
$1.08M Sell
19,798
-565
-3% -$27K ﹤0.01% 1143
2017
Q1
$858K Buy
20,363
+373
+2% +$15.9K ﹤0.01% 1242
2016
Q4
$858K Sell
19,990
-3,098
-13% -$126K ﹤0.01% 1245
2016
Q3
$952K Sell
23,088
-1,184
-5% -$49.6K ﹤0.01% 1173
2016
Q2
$969K Sell
24,272
-800
-3% -$28.8K ﹤0.01% 1157
2016
Q1
$844K Buy
25,072
+5,842
+30% +$182K ﹤0.01% 1224
2015
Q4
$652K Sell
19,230
-6,372
-25% -$199K ﹤0.01% 1259
2015
Q3
$762K Buy
25,602
+4,338
+20% +$136K ﹤0.01% 1238
2015
Q2
$716K Buy
21,264
+1,156
+6% +$37.7K ﹤0.01% 1316
2015
Q1
$619K Buy
20,108
+494
+3% +$14.3K ﹤0.01% 1338
2014
Q4
$532K Buy
19,614
+3,064
+19% +$76K ﹤0.01% 1362
2014
Q3
$411K Sell
16,550
-2,800
-14% -$68.2K ﹤0.01% 1419
2014
Q2
$456K Hold
19,350
– – ﹤0.01% 1321
2014
Q1
$445K Buy
19,350
+150
+0.8% +$3.54K ﹤0.01% 1302
2013
Q4
$458K Sell
19,200
-2,056
-10% -$46.1K ﹤0.01% 1268
2013
Q3
$428K Buy
21,256
+56
+0.3% +$1.1K ﹤0.01% 1286
2013
Q2
$388K Hold
21,200
– – ﹤0.01% 1270

Other funds holding IART

PNC Financial Services Group's IART Position: Q3 2026 in Review

PNC Financial Services Group held its Integra LifeSciences (IART) position steady in Q3 2026 at 11,623 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #2432.

PNC Financial Services Group first reported a position in IART in Q2 2013 and has held it in 54 quarters since. The position peaked at $3.63M in Q3 2018. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • PNC Financial Services Group held 11,623 shares of Integra LifeSciences worth $189K as of Q3 2026.
  • PNC Financial Services Group left its Integra LifeSciences share count unchanged in Q3 2026.
  • Integra LifeSciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #2432 holding.
  • PNC Financial Services Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 54 quarters since.
  • PNC Financial Services Group's Integra LifeSciences position peaked at $3.63M in Q3 2018.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.